Similar results were obtained in which NDRG1 defined a PCa subgroup with intermediate-risk and YWHAZ defined a PCa subgroup with high risk, regarding disease-specific survival (DSS) (TCGA-PRAD and Jenkins) and relapse-free survival (RFS) (Ross-Adams) for all PCa patients (Fig. 5b, d, g). Here, NDRG1 is linked to posterior cortical atrophy.